[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xencor Inc (XNCR)

Xencor Inc (XNCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xencor Inc 465 NORTH HALSTEAD STREET SUITE 200 PASADENA CA 91107 USA

www.xencor.com Employees: 260 P: 626-305-5900

Sector:

Medical

Description:

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

Key Statistics

Overview:

Market Capitalization, $K 1,394,611
Enterprise Value, $K 1,460,291
Shares Outstanding, K 74,142
Float, K 70,376
% Float 94.92%
Short Interest, K 11,506
Short Float 15.52%
Days to Cover 9.71
Short Volume Ratio 0.69
% of Insider Shareholders 5.08%

Financials:

Annual Sales, $ 125,580 K
Annual Net Income, $ -91,920 K
Last Quarter Sales, $ 4,520 K
Last Quarter Net Income, $ -128,920 K
EBIT, $ -212,180 K
EBITDA, $ -205,150 K

Growth:

1-Year Return 126.04%
3-Year Return -21.59%
5-Year Return -38.89%
5-Year Revenue Growth 2.36%
5-Year Earnings Growth -2.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.71 on 05/06/26
Next Earnings Date 08/05/26 [--]
Earnings Per Share ttm -2.29
EPS Growth vs. Prev Qtr -1,800.00%
EPS Growth vs. Prev Year -159.09%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

XNCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.77%
Return-on-Assets % -20.52%
Profit Margin % -73.20%
Debt/Equity 0.00
Price/Sales 10.31
Price/Cash Flow N/A
Price/Book 2.51
Book Value/Share 6.96
Interest Coverage -1.81
60-Month Beta 0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.